Issue 4/2003
Content (13 Articles)
Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: Rationale and options
Guido Grassi
Has the role of calcium channel blockers in treating hypertension finally been defined?
George S. Chrysant, Steven G. Chrysant
Regression of left ventricular hypertrophy is a key goal of hypertension management
Rubin Zhang, Judy Crump, Efrain Reisin
Ongoing trials: What should we expect after ALLHAT?
Ji-Guang Wang, Jan A. Staessen, Anthony M. Heagerty
Recent clinical trials with omapatrilat: New developments
Anne Zanchi, Marc Maillard, Michel Burnier